Chronic myeloid leukemiaGeriatric oncologyTargeted therapyTyrosine kinase inhibitorsQuality of lifeChronic myeloid leukemia (CML), a myeloproliferative neoplasm defined by the t(9;22)(q34;q11) chromosomal translocation, primarily affects older adults. Historically, effective treatment options were not ...
Talk to your doctor about potential side effects. EXPLORE SIDE EFFECTS What is ICLUSIG? ICLUSIG is a prescription medicine used to treat adults who have: Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) in combination with chemotherapy in newly diagnosed Ph+ ALL* ...
Chronic myeloid leukemia (CML) rarely occurs in the first few decades of life, accounting for 2% to 3% of leukemias in children and adolescents.1,2 Epidemiologic data show an incidence of 0.6 to 1.2 per million children/year that increases with age: CML is exceptionally rare in infancy, and...
How I treat Philadelphia chromosome–positive acute lymphoblastic leukemia Background: Ponatinib is a potent, third-generation inhibitor of BCR-ABL that is active against T315I mutations of the ABL1 gene; these mutations are a common mechanism of resistance to earlier-generation BCR-ABL tyrosine kina...
Imatinibis an oral medication used to treat chronic myeloid leukemia (CML) in adult patients who are positive for the Philadelphia chromosome (Ber-Abl). Imatinib 152459-95-5 Imatinib Mesylate 220127-57-1 Imatinib Intermediate 1 106261-49-8 ...
10月28日16:00-17:00,由中国临床肿瘤学会(CSCO)与良医汇共同主办的【How we treat·天肿经验】系列直播会议拉开帷幕。本期直播主题为“滤泡性淋巴瘤治疗指征及治疗目标的把握”,由天津医科大学肿瘤医院张会来教授领衔,天津医科...
11月26日16:00-17:30,由中国临床肿瘤学会(CSCO)与良医汇共同主办的【How we treat·天肿经验】系列直播会议拉开帷幕。本期直播主题为“滤泡性淋巴瘤的一线治疗方案:不同药物、多种方案,如何选择?”,由天津医科大学肿瘤医院张会...
Although curing the leukemia is always the most formidable challenge, complications from the disease itself and its treatment are associated with significant morbidity and mortality. Such complications, discussed herein, include tumor lysis, hyperleukocytosis, cytarabine-induced cellebellar toxicity, acute ...
Acute Myeloid Leukemia (AML) is a genetically heterogeneous malignant disease mainly occurring in elderly patients. The prognosis of patients over 60 years of age, which represent the majority of patients, which are diagnosed, remains poor. The main reasons for the poor outcome are the in-creasing...
Anthracyclines are widely used to treat ... DM Walker,BT Fisher,AE Seif,... - 《Pediatric Blood & Cancer》 被引量: 49发表: 2013年 How I treat T-cell acute lymphoblastic leukemia in adults. T-cell immunophenotype of acute lymphoblastic leukemia (T-ALL) is an uncommon aggressive leukemia ...